Shandong Risen-Sun Pharmaceutical Co., Ltd.

Produces active pharmaceutical ingredients and intermediates, and offers custom development and manufacturing. Its declared therapeutic areas are respiratory, central nervous system, glucocorticoids and antineoplastics. Its plant in the Ningyang chemical park covers 204,000 square metres and completed trial production in 2023. It reports Australian GMP certification and 277 employees. A subsidiary of Jewim Pharmaceutical.